Loading clinical trials...
Loading clinical trials...
Until now, the development of personalized medicine in oncology has relied on the use of somatic biomarkers to help therapists choose the right molecule(s) to administer, based on the genetic and mole...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT06656494 · Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
NCT06465953 · Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)
NCT04064060 · Myelodysplastic Syndromes (MDS), Beta-thalassemia, and more
NCT06398457 · Hematologic Malignancy, Bone Marrow Transplant Rejection, and more
NCT04275518 · Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Hôpital de la Conception
Marseille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions